Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Primary squamous carcinoma of breast - a rare entity: report of two cases and review of the literature.

Vythianathan M, Fox P, Rhodes G, Armes JE.

Pathology. 2019 Jun 12. pii: S0031-3025(18)31080-8. doi: 10.1016/j.pathol.2019.03.003. [Epub ahead of print] No abstract available.

PMID:
31202482
2.

Improved relapse-free survival on aromatase inhibitors in breast cancer is associated with interaction between oestrogen receptor-α and progesterone receptor-b.

Snell CE, Gough M, Liu C, Middleton K, Pyke C, Shannon C, Woodward N, Hickey TE, Armes JE, Tilley WD.

Br J Cancer. 2018 Nov;119(11):1316-1325. doi: 10.1038/s41416-018-0331-3. Epub 2018 Nov 9.

PMID:
30410061
3.

L1 Retrotransposon Heterogeneity in Ovarian Tumor Cell Evolution.

Nguyen THM, Carreira PE, Sanchez-Luque FJ, Schauer SN, Fagg AC, Richardson SR, Davies CM, Jesuadian JS, Kempen MHC, Troskie RL, James C, Beaven EA, Wallis TP, Coward JIG, Chetty NP, Crandon AJ, Venter DJ, Armes JE, Perrin LC, Hooper JD, Ewing AD, Upton KR, Faulkner GJ.

Cell Rep. 2018 Jun 26;23(13):3730-3740. doi: 10.1016/j.celrep.2018.05.090.

4.

Histologic Evaluation of Explanted Tissue-Engineered Bovine Pericardium (CardioCel).

Prabhu S, Armes JE, Bell D, Justo R, Venugopal P, Karl T, Alphonso N.

Semin Thorac Cardiovasc Surg. 2017 Autumn;29(3):356-363. doi: 10.1053/j.semtcvs.2017.05.017. Epub 2017 Jun 1.

PMID:
29195576
5.

Ectopic Intralaryngo-Tracheal Thyroid Tissue Causing Neonatal Death.

Furnas L, Safa H, Hutchinson F, Joseph L, Armes JE.

Fetal Pediatr Pathol. 2017 Oct;36(5):412-415. doi: 10.1080/15513815.2017.1336659. Epub 2017 Jul 27.

PMID:
28749718
6.

Application of Whole Genome Sequencing Technology in the Investigation of Genetic Causes of Fetal, Perinatal, and Early Infant Death.

Armes JE, Williams M, Price G, Wallis T, Gallagher R, Matsika A, Joy C, Galea M, Gardener G, Leach R, Swagemakers SM, Tearle R, Stubbs A, Harraway J, van der Spek PJ, Venter DJ.

Pediatr Dev Pathol. 2018 Jan-Feb;21(1):54-67. doi: 10.1177/1093526617715528. Epub 2017 Jun 22.

PMID:
28641477
7.

Isolated Ventricular Noncompaction Cardiomyopathy Presenting as Fetal Hydrops at 24 Weeks Gestation.

Armes JE, Squires L, Lourie R, Williams M, Gallagher R, Price G, Stubbs A, Swagemakers SM, van der Spek PJ, Harraway J, Thomas J, Venter DJ.

Pediatr Dev Pathol. 2017 Jun;20(3):245-250. doi: 10.1177/1093526616686235. Epub 2017 Jan 25.

PMID:
28521630
8.

Absent progesterone receptor expression in the lymph node metastases of ER-positive, HER2-negative breast cancer is associated with relapse on tamoxifen.

Snell CE, Gough M, Middleton K, Hsieh M, Furnas L, Seidl B, Gibbons K, Pyke C, Shannon C, Woodward N, Armes JE.

J Clin Pathol. 2017 Nov;70(11):954-960. doi: 10.1136/jclinpath-2016-204304. Epub 2017 Apr 17.

PMID:
28416639
9.

The outcome of papillary lesions of the breast diagnosed by standard core needle biopsy within a BreastScreen Australia service.

Armes JE, Galbraith C, Gray J, Taylor K.

Pathology. 2017 Apr;49(3):267-270. doi: 10.1016/j.pathol.2016.12.346. Epub 2017 Feb 24.

PMID:
28238415
10.

Extracorporeal Life Support in Multisystem Smooth Muscle Dysfunction Syndrome.

Prabhu S, Fox S, Mattke A, Armes JE, Alphonso N.

World J Pediatr Congenit Heart Surg. 2017 Nov;8(6):750-753. doi: 10.1177/2150135116658457. Epub 2016 Aug 22.

PMID:
27549731
11.

Surgical safety and personal costs in morbidly obese, multimorbid patients diagnosed with early-stage endometrial cancer having a hysterectomy.

Obermair A, Brennan DJ, Baxter E, Armes JE, Gebski V, Janda M.

Gynecol Oncol Res Pract. 2016 Feb 9;3:1. doi: 10.1186/s40661-016-0023-8. eCollection 2016.

12.

Interstitial lung disease in infancy: A general approach.

Hines EJ, Walsh M, Armes JE, Douglas T, Chawla J.

J Paediatr Child Health. 2016 Apr;52(4):370-6. doi: 10.1111/jpc.13162. Review.

PMID:
27145498
13.

Ovarian Microcystic Stromal Tumor: A Rare Clinical Manifestation of Familial Adenomatous Polyposis.

Liu C, Gallagher RL, Price GR, Bolton E, Joy C, Harraway J, Venter DJ, Armes JE.

Int J Gynecol Pathol. 2016 Nov;35(6):561-565.

PMID:
27015438
14.

Cell line and patient-derived xenograft models reveal elevated CDCP1 as a target in high-grade serous ovarian cancer.

Harrington BS, He Y, Davies CM, Wallace SJ, Adams MN, Beaven EA, Roche DK, Kennedy C, Chetty NP, Crandon AJ, Flatley C, Oliveira NB, Shannon CM, deFazio A, Tinker AV, Gilks CB, Gabrielli B, Brennan DJ, Coward JI, Armes JE, Perrin LC, Hooper JD.

Br J Cancer. 2016 Feb 16;114(4):417-26. doi: 10.1038/bjc.2015.471. Epub 2016 Feb 4.

15.

Elevated CDCP1 predicts poor patient outcome and mediates ovarian clear cell carcinoma by promoting tumor spheroid formation, cell migration and chemoresistance.

He Y, Wu AC, Harrington BS, Davies CM, Wallace SJ, Adams MN, Palmer JS, Roche DK, Hollier BG, Westbrook TF, Hamidi H, Konecny GE, Winterhoff B, Chetty NP, Crandon AJ, Oliveira NB, Shannon CM, Tinker AV, Gilks CB, Coward JI, Lumley JW, Perrin LC, Armes JE, Hooper JD.

Oncogene. 2016 Jan 28;35(4):468-78. doi: 10.1038/onc.2015.101. Epub 2015 Apr 20.

16.

Diffuse lung disease of infancy: a pattern-based, algorithmic approach to histological diagnosis.

Armes JE, Mifsud W, Ashworth M.

J Clin Pathol. 2015 Feb;68(2):100-10. doi: 10.1136/jclinpath-2014-202685. Epub 2014 Dec 4. Review.

17.

EGF inhibits constitutive internalization and palmitoylation-dependent degradation of membrane-spanning procancer CDCP1 promoting its availability on the cell surface.

Adams MN, Harrington BS, He Y, Davies CM, Wallace SJ, Chetty NP, Crandon AJ, Oliveira NB, Shannon CM, Coward JI, Lumley JW, Perrin LC, Armes JE, Hooper JD.

Oncogene. 2015 Mar 12;34(11):1375-83. doi: 10.1038/onc.2014.88. Epub 2014 Mar 31.

PMID:
24681947
18.

AGR2 expression in ovarian tumours: a potential biomarker for endometrioid and mucinous differentiation.

Armes JE, Davies CM, Wallace S, Taheri T, Perrin LC, Autelitano DJ.

Pathology. 2013 Jan;45(1):49-54. doi: 10.1097/PAT.0b013e32835bd561.

PMID:
23222243
19.

The placenta in Beckwith-Wiedemann syndrome: genotype-phenotype associations, excessive extravillous trophoblast and placental mesenchymal dysplasia.

Armes JE, McGown I, Williams M, Broomfield A, Gough K, Lehane F, Lourie R.

Pathology. 2012 Oct;44(6):519-27.

PMID:
22772341
20.

Assessing HER2 amplification in breast cancer: findings from the Australian In Situ Hybridization Program.

Bilous M, Morey AL, Armes JE, Bell R, Button PH, Cummings MC, Fox SB, Francis GD, Waite B, McCue G, Raymond WA, Robbins PD, Farshid G.

Breast Cancer Res Treat. 2012 Jul;134(2):617-24. doi: 10.1007/s10549-012-2093-6. Epub 2012 Jun 8.

21.

Gastric HER2 Testing Study (GaTHER): an evaluation of gastric/gastroesophageal junction cancer testing accuracy in Australia.

Fox SB, Kumarasinghe MP, Armes JE, Bilous M, Cummings MC, Farshid G, Fitzpatrick N, Francis GD, McCloud PI, Raymond W, Morey A.

Am J Surg Pathol. 2012 Apr;36(4):577-82. doi: 10.1097/PAS.0b013e318244adbb.

PMID:
22314190
22.

Bodyweight and other correlates of symptom-detected breast cancers in a population offered screening.

Kricker A, Disipio T, Stone J, Goumas C, Armes JE, Gertig DM, Armstrong BK.

Cancer Causes Control. 2012 Jan;23(1):89-102. doi: 10.1007/s10552-011-9858-9. Epub 2011 Oct 22.

PMID:
22020871
23.

Genetic segregation of inflammatory lung disease and autoimmune disease severity in SHIP-1-/- mice.

Maxwell MJ, Duan M, Armes JE, Anderson GP, Tarlinton DM, Hibbs ML.

J Immunol. 2011 Jun 15;186(12):7164-75. doi: 10.4049/jimmunol.1004185. Epub 2011 May 13.

24.

Establishment of the Australian in situ hybridization program for the assessment of HER2 amplification in breast cancer: a model for the introduction of new biomarkers into clinical practice.

Farshid G, Armes JE, Bell R, Cummings M, Fox S, Francis G, Haswell M, Morey A, McCue G, Raymond W, Robbins P, Bilous M.

Diagn Mol Pathol. 2010 Dec;19(4):187-93. doi: 10.1097/PDM.0b013e3181e1cc9d.

PMID:
21052003
25.

Differential diagnosis of serous papillary carcinoma of the gynaecological tract and basal breast carcinoma: an immunohistochemical approach.

Armes JE, Bowlay G, Lourie R, Venter DJ, Price G.

Pathology. 2010;42(6):534-9. doi: 10.3109/00313025.2010.508793.

PMID:
20854071
26.

Preliminary comparison of tumor biologic factors in breast carcinomas from Australian and Chinese women.

Zheng W, Armes JE, Slavin J, Zhu Y, Ni C.

Anal Quant Cytol Histol. 2010 Jun;32(3):155-60.

PMID:
20701069
27.

Increased plasma concentrations of anterior gradient 2 protein are positively associated with ovarian cancer.

Edgell TA, Barraclough DL, Rajic A, Dhulia J, Lewis KJ, Armes JE, Barraclough R, Rudland PS, Rice GE, Autelitano DJ.

Clin Sci (Lond). 2010 Mar 30;118(12):717-25. doi: 10.1042/CS20090537. Erratum in: Clin Sci (Lond). 2010;119(6):263.

PMID:
20136634
28.

Effects of life event stress and social support on the odds of a >or= 2 cm breast cancer.

Kricker A, Price M, Butow P, Goumas C, Armes JE, Armstrong BK.

Cancer Causes Control. 2009 May;20(4):437-47. doi: 10.1007/s10552-008-9257-z. Epub 2008 Nov 8.

PMID:
18998218
29.
30.
31.

Ductal carcinoma in situ arising in an epithelial inclusion within an axillary lymph node.

Srinivasan B, Allan CP, Armes JE.

Pathology. 2007 Apr;39(2):268-9. No abstract available.

PMID:
17454760
32.

Phenotype-directed analysis of genotype in early-onset, familial breast cancers.

Price GR, Armes JE, Ramus SJ, Provenzano E, Kumar B, Cowie TF, Ciciulla J, Hutchins AM, Thomas M, Venter DJ.

Pathology. 2006 Dec;38(6):520-7.

PMID:
17393978
33.

Abnormalities of the RB1 pathway in ovarian serous papillary carcinoma as determined by overexpression of the p16(INK4A) protein.

Armes JE, Lourie R, de Silva M, Stamaratis G, Boyd A, Kumar B, Price G, Hyde S, Allen D, Grant P, Venter DJ.

Int J Gynecol Pathol. 2005 Oct;24(4):363-8.

PMID:
16175083
34.

Complex CGH alterations on chromosome arm 8p at candidate tumor suppressor gene loci in breast cancer cell lines.

Venter DJ, Ramus SJ, Hammet FM, de Silva M, Hutchins AM, Petrovic V, Price G, Armes JE.

Cancer Genet Cytogenet. 2005 Jul 15;160(2):134-40.

PMID:
15993269
35.

Common origins of MDA-MB-435 cells from various sources with those shown to have melanoma properties.

Rae JM, Ramus SJ, Waltham M, Armes JE, Campbell IG, Clarke R, Barndt RJ, Johnson MD, Thompson EW.

Clin Exp Metastasis. 2004;21(6):543-52.

36.

LCC15-MB cells are MDA-MB-435: a review of misidentified breast and prostate cell lines.

Thompson EW, Waltham M, Ramus SJ, Hutchins AM, Armes JE, Campbell IG, Williams ED, Thompson PR, Rae JM, Johnson MD, Clarke R.

Clin Exp Metastasis. 2004;21(6):535-41.

PMID:
15679051
37.

Tissue microarrays: a practical guide.

Kumar B, De Silva M, Venter DJ, Armes JE.

Pathology. 2004 Aug;36(4):295-300. Review.

PMID:
15370126
38.

Histological markers that predict clinical recurrence in ductal carcinoma in situ of the breast: an Australian population-based study.

Provenzano E, Hopper JL, Giles GG, Marr G, Venter DJ, Armes JE.

Pathology. 2004 Jun;36(3):221-9.

PMID:
15203725
39.

Candidate tumor-suppressor genes on chromosome arm 8p in early-onset and high-grade breast cancers.

Armes JE, Hammet F, de Silva M, Ciciulla J, Ramus SJ, Soo WK, Mahoney A, Yarovaya N, Henderson MA, Gish K, Hutchins AM, Price GR, Venter DJ.

Oncogene. 2004 Jul 22;23(33):5697-702.

PMID:
15184884
40.

A specific GFP expression assay, penetrance estimate, and histological assessment for a putative splice site mutation in BRCA1.

Southey MC, Tesoriero A, Young MA, Holloway AJ, Jenkins MA, Whitty J, Misfud S, kConFab, McLachlan SA, Venter DJ, Armes JE.

Hum Mutat. 2003 Jul;22(1):86-91.

PMID:
12815598
41.

Chromosomal gains and losses in ocular melanoma detected by comparative genomic hybridization in an Australian population-based study.

Vajdic CM, Hutchins AM, Kricker A, Aitken JF, Armstrong BK, Hayward NK, Armes JE.

Cancer Genet Cytogenet. 2003 Jul 1;144(1):12-7.

PMID:
12810250
42.

Searching for candidate genes for male infertility.

Truong BN, Moses EK, Armes JE, Venter DJ, Baker HW.

Asian J Androl. 2003 Jun;5(2):137-47. Erratum in: Asian J Androl. 2003 Sep;5(3):230.

43.

Cotyledonoid dissecting leiomyoma.

Stewart KA, Ireland-Jenkin K, Quinn M, Armes JE.

Pathology. 2003 Apr;35(2):177-9. No abstract available.

PMID:
12745471
44.

Biological markers that predict clinical recurrence in ductal carcinoma in situ of the breast.

Provenzano E, Hopper JL, Giles GG, Marr G, Venter DJ, Armes JE.

Eur J Cancer. 2003 Mar;39(5):622-30.

PMID:
12628841
45.

Detailed gene copy number and RNA expression analysis of the 17q12-23 region in primary breast cancers.

Willis S, Hutchins AM, Hammet F, Ciciulla J, Soo WK, White D, van der Spek P, Henderson MA, Gish K, Venter DJ, Armes JE.

Genes Chromosomes Cancer. 2003 Apr;36(4):382-92.

PMID:
12619162
46.

The pathology of inherited breast cancer.

Armes JE, Venter DJ.

Pathology. 2002 Aug;34(4):309-14. Review.

PMID:
12190286
47.

Genetic aberrations detected by comparative genomic hybridisation in vulvar cancers.

Allen DG, Hutchins AM, Hammet F, White DJ, Scurry JP, Tabrizi SN, Garland SM, Armes JE.

Br J Cancer. 2002 Mar 18;86(6):924-8.

48.

Stanniocalcin 2 is an estrogen-responsive gene coexpressed with the estrogen receptor in human breast cancer.

Bouras T, Southey MC, Chang AC, Reddel RR, Willhite D, Glynne R, Henderson MA, Armes JE, Venter DJ.

Cancer Res. 2002 Mar 1;62(5):1289-95.

49.

Molecular pathologic analysis enhances the diagnosis and management of Muir-Torre syndrome and gives insight into its underlying molecular pathogenesis.

Southey MC, Young MA, Whitty J, Mifsud S, Keilar M, Mead L, Trute L, Aittomäki K, McLachlan SA, Debinski H, Venter DJ, Armes JE.

Am J Surg Pathol. 2001 Jul;25(7):936-41.

PMID:
11420466
50.

Progressive genetic aberrations detected by comparative genomic hybridization in squamous cell cervical cancer.

Allen DG, White DJ, Hutchins AM, Scurry JP, Tabrizi SN, Garland SM, Armes JE.

Br J Cancer. 2000 Dec;83(12):1659-63.

Supplemental Content

Loading ...
Support Center